ERBB2 and breast neoplasm: While the first molecular portraits of breast tumors using DNA microarrays suggested that breast carcinomas with a basal phenotype are HER2 non-amplified [11], subsequent refined analyses tended to include HER2-amplified tumors branching close or included in a bona fide basal-like subclass [12–15].